| 11975100 |
Process for preparing pharmaceutical compositions |
Luke Ryan Schenck, David J. Lamberto, Joseph L. Kukura, II, Francisco J. Guzman, Athanas Koynov |
2024-05-07 |
| 11858904 |
Process for preparing large size isoxazoline particles |
Luke Ryan Schenck, Athanas Koynov, George X. Zhou |
2024-01-02 |
| 9272999 |
Crystalline polymorphic forms of an antidiabetic compound |
John Y. L. Chung, Yanfeng Zhang, Jeremy Scott, Yekaterina Vaynshteyn |
2016-03-01 |
| 9012488 |
Crystalline polymorphic forms of an antidiabetic compound |
John Y. L. Chung, Yanfeng Zhang, Laura Artino, Donal Desmond, Jeremy Scott +1 more |
2015-04-21 |
| 8796452 |
Preparation of lamivudine form I |
Benjamin M. Cohen, Christopher Wahl, Itzia Arroyo |
2014-08-05 |
| 8697740 |
Crystalline polymorphic forms of an antidiabetic compound |
John Y. L. Chung, Yanfeng Zhang, Laura Artino, Jennifer Baxter, Yekaterina Vaynshteyn +2 more |
2014-04-15 |
| 8450372 |
Formulations of suberoylanilide hydroxamic acid and methods for producing same |
Jeannie Chow Wong, Erik A. Dienemann, Kimberly Gallagher, Craig B. Ikeda, Justin Moser +9 more |
2013-05-28 |
| 8288440 |
Formulations of suberoylanilide hydroxamic acid and methods for producing same |
Jeannie Chow Wong, Erik A. Dienemann, Kimberly Gallagher, Craig B. Ikeda, Justin Moser +8 more |
2012-10-16 |
| 8232413 |
Process for the production of a crystalline glucagon receptor antagonist compound |
Benjamin M. Cohen, Daniel J. Kumke, Lushi Tan |
2012-07-31 |
| 8093295 |
Formulations of suberoylanilide hydroxamic acid and methods for producing the same |
Jeannie Chow Wong, Benjamin M. Cohen, Erik A. Dienemann, Kimberly Gallagher, Craig B. Ikeda +8 more |
2012-01-10 |
| 7863307 |
Process for synthesizing a CETP inhibitor |
Ross A. Miller |
2011-01-04 |
| 7365202 |
Polymorphs of an androgen receptor modulator |
Lushi Tan, Robert S. Meissner, Wenjie Li, James J. Perkins, Joyce Stellabott +1 more |
2008-04-29 |
